| Dr David Manno, DO | |
|
1100 Lake St Ste 125b, Oak Park, IL 60301-1015 | |
| (708) 334-8075 | |
| Not Available |
| Full Name | Dr David Manno |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 30 Years |
| Location | 1100 Lake St Ste 125b, Oak Park, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215938857 | NPI | - | NPPES |
| 036093261 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036093261 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush Oak Park Hospital | Oak park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush Oak Park Er Physicians Group | 8820190606 | 33 |
News Archive
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
In this post in the Human Rights and HIV/AIDS "Now More Than Ever" blog, Michel Kazatchkine, the former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and newly appointed special envoy to U.N. Secretary-General Ban Ki-moon for HIV/AIDS in Eastern Europe and Central Asia, examines why human rights are "so central to the AIDS response."
Communities in high income countries around the world continue to receive record-setting numbers of newcomers fleeing armed conflict.
› Verified 1 days ago
| Entity Name | Rush Oak Park Er Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447260880 PECOS PAC ID: 8820190606 Enrollment ID: O20070226000187 |
News Archive
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
In this post in the Human Rights and HIV/AIDS "Now More Than Ever" blog, Michel Kazatchkine, the former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and newly appointed special envoy to U.N. Secretary-General Ban Ki-moon for HIV/AIDS in Eastern Europe and Central Asia, examines why human rights are "so central to the AIDS response."
Communities in high income countries around the world continue to receive record-setting numbers of newcomers fleeing armed conflict.
› Verified 1 days ago
| Entity Name | Midwest Alternative Treatment Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104439777 PECOS PAC ID: 3870904899 Enrollment ID: O20201124000834 |
News Archive
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
In this post in the Human Rights and HIV/AIDS "Now More Than Ever" blog, Michel Kazatchkine, the former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and newly appointed special envoy to U.N. Secretary-General Ban Ki-moon for HIV/AIDS in Eastern Europe and Central Asia, examines why human rights are "so central to the AIDS response."
Communities in high income countries around the world continue to receive record-setting numbers of newcomers fleeing armed conflict.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Manno, DO 1100 Lake St Ste 125b, Oak Park, IL 60301-1015 Ph: (708) 334-8075 | Dr David Manno, DO 1100 Lake St Ste 125b, Oak Park, IL 60301-1015 Ph: (708) 334-8075 |
News Archive
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
In this post in the Human Rights and HIV/AIDS "Now More Than Ever" blog, Michel Kazatchkine, the former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and newly appointed special envoy to U.N. Secretary-General Ban Ki-moon for HIV/AIDS in Eastern Europe and Central Asia, examines why human rights are "so central to the AIDS response."
Communities in high income countries around the world continue to receive record-setting numbers of newcomers fleeing armed conflict.
› Verified 1 days ago
Dr. Katrina Weimer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14 Lake St, Oak Park, IL 60302 Phone: 708-383-0113 | |
Nupur Shah, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 S Maple Ave, Oak Park, IL 60304 Phone: 708-660-5997 | |
Richard Schmitt, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 708-383-6200 | |
Steven Ross, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 708-383-6200 | |
Dr. Colin Therriault, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 520 S Maple Ave, Oak Park, IL 60304 Phone: 708-660-5997 | |
Steven Rockoff, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 708-383-6200 |